SGMT: Sagimet Biosciences Inc - Series A
SGMT exchange rate has changed by 1.64% for today. During the day, the instrument was traded at a low of 9.72 and at a high of 10.21.
Follow Sagimet Biosciences Inc - Series A dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SGMT News
- Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet
- After Plunging 27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)
- Sagimet Biosciences To Present 52-Week Results From Its Phase 3 ASC40-304 Open-Label Extension Of Denifanstat In Patients With Moderate To Severe Acne Vulgaris At The 2026 Fall Clinical Dermatology Conference, October 8-11
- HC Wainwright & Co. Reiterates Buy on Sagimet Biosciences, Maintains $29 Price Target
- Guggenheim Maintains Buy on Sagimet Biosciences, Raises Price Target to $26
- Oppenheimer Maintains Outperform on Sagimet Biosciences, Raises Price Target to $38
- Citizens Maintains Market Outperform on Sagimet Biosciences, Lowers Price Target to $27
- Sagimet Biosciences Inc. (SGMT) Discusses 52-Week Phase 3 Data and U.S. Phase 3 Plans for Denifanstat in Moderate to Severe Acne Transcript
- Sagimet Biosciences Surges Forward With Successful Acne Clinical Data and Capital Raise
- Sagimet Biosciences Prices $115M Offer Of 8,750,010 Shares And Warrants At $10.00/Unit
- Sagimet Biosciences Suspends And Terminates August 14 Prospectus Supplement Regarding ATM Sales Agreement With Leerink
- Sagimet Biosciences Announces 52-week Results From The Phase 3 ASC40-304 OLE Trial Of Denifanstat In Patients With Moderate To Severe Acne Vulgaris; Denifanstat Showed Progressive And Sustained Improvements Across All Efficacy Endpoints In The OLE...
Frequently Asked Questions
What is SGMT stock price today?
Sagimet Biosciences Inc - Series A stock is priced at 9.90 today. It trades within 9.72 - 10.21, yesterday's close was 9.74, and trading volume reached 1908. The live price chart of SGMT shows these updates.
Does Sagimet Biosciences Inc - Series A stock pay dividends?
Sagimet Biosciences Inc - Series A is currently valued at 9.90. Dividend policy depends on the company, while investors also watch 17.02% and USD. View the chart live to track SGMT movements.
How to buy SGMT stock?
You can buy Sagimet Biosciences Inc - Series A shares at the current price of 9.90. Orders are usually placed near 9.90 or 10.20, while 1908 and 1.43% show market activity. Follow SGMT updates on the live chart today.
How to invest into SGMT stock?
Investing in Sagimet Biosciences Inc - Series A involves considering the yearly range 4.50 - 11.45 and current price 9.90. Many compare 2.80% and 22.07% before placing orders at 9.90 or 10.20. Explore the SGMT price chart live with daily changes.
What are Sagimet Biosciences Inc - Series A stock highest prices?
The highest price of Sagimet Biosciences Inc - Series A in the past year was 11.45. Within 4.50 - 11.45, the stock fluctuated notably, and comparing with 9.74 helps spot resistance levels. Track Sagimet Biosciences Inc - Series A performance using the live chart.
What are Sagimet Biosciences Inc - Series A stock lowest prices?
The lowest price of Sagimet Biosciences Inc - Series A (SGMT) over the year was 4.50. Comparing it with the current 9.90 and 4.50 - 11.45 shows potential long-term entry points. Watch SGMT moves on the chart live for more details.
When did SGMT stock split?
Sagimet Biosciences Inc - Series A has gone through stock splits historically. These changes are visible in , 9.74, and 17.02% after corporate actions.
- Previous Close
- 9.74
- Open
- 9.76
- Bid
- 9.90
- Ask
- 10.20
- Low
- 9.72
- High
- 10.21
- Volume
- 1.908 K
- Daily Change
- 1.64%
- Month Change
- 2.80%
- 6 Months Change
- 22.07%
- Year Change
- 17.02%
- Act
- -3.060 M
- Fcst
- -4.804 M
- Prev
- -8.557 M
- Act
- 0.987 M
- Fcst
- -0.153 M
- Prev
- 1.862 M
- Act
- Fcst
- Prev
- 5.420%